|
Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
Aranha O, Agulnik M
Expert opinion on therapeutic targets. 2008;12(2):197-207.
PMID: 18208368
Nasopharyngeal carcinoma: Current management, future directions and dental implications.
Agulnik M, Epstein JB
Oral oncology. 2007 Nov.
PMID: 18061518
Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, Daneshmand M, Ho J, Tsao MS, Siu LL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(25):3978-84.
PMID: 17761983
Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma.
Elser C, Siu LL, Winquist E, Agulnik M, Pond GR, Chin SF, Francis P, Cheiken R, Elting J, McNabola A, Wilkie D, Petrenciuc O, Chen EX
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(24):3766-73.
PMID: 17704426
Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinib.
Agulnik M, da Cunha Santos G, Hedley D, Nicklee T, Dos Reis PP, Ho J, Pond GR, Chen H, Chen S, Shyr Y, Winquist E, Soulieres D, Chen EX, Squire JA, Marrano P, Kamel-Reid S, Dancey J, Siu LL, Tsao MS
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(16):2184-90.
PMID: 17538163
Malignancies of the head and neck: the role for molecular targeted agents.
Agulnik M
Expert opinion on therapeutic targets. 2007;11(2):207-17.
PMID: 17227235
The changing management of low-grade astrocytomas and oligodendrogliomas.
Agulnik M, Mason WP
Hematology/oncology clinics of North America. 2006 Dec;20(6):1249-66.
PMID: 17113461
Recent advances in the treatment of oligodendrogliomas.
Agulnik M, Mason WP
Current neurology and neuroscience reports. 2006;6(3):212-7.
PMID: 16635430
Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USA.
Agulnik M, Siu LL
Expert opinion on pharmacotherapy. 2006;7(4):489-94.
PMID: 16503821
Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.
Agulnik M, Oza AM, Pond GR, Siu LL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(30):4801-7.
PMID: 17050865
Paclitaxel, carboplatin, and concomitant radiotherapy for resected patients with high risk head and neck cancer.
Agulnik M, Rhee EN, Yao M, Mundt AJ, Feldman LE
Journal of chemotherapy (Florence, Italy). 2005;17(2):237-41.
PMID: 15920912
State-of-the-art management of nasopharyngeal carcinoma: current and future directions.
Agulnik M, Siu LL
British journal of cancer. 2005;92(5):799-806.
PMID: 15756250
An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents.
Agulnik M, Siu LL
Current medicinal chemistry. Anti-cancer agents. 2004 Nov;4(6):543-51.
PMID: 15579019
Integrative tumor board: colon cancer with liver metastases: case presentation.
Schmaltz JR, Agulnik M, Mullane MR, De La Torre M, Block KI, Robertson S, Dixon SW, Broffman M, McCulloch M, Gao J, Perlman MI, Hurst CV
Integrative cancer therapies. 2003;2(2):166-198.
PMID: 15035907
Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
Angelotta C, McKoy JM, Fisher MJ, Buffie CG, Barfi K, Ramsey G, Frohlich L, Bennett CL
Vox sanguinis. 2007;93(2):159-65.
PMID: 17683360
The sound and the fury: financial conflicts of interest in oncology.
Djulbegovic B, Angelotta C, Knox KE, Bennett CL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(24):3567-9.
PMID: 17704401
Process Evaluation in an Intervention Designed to Improve Rates of Colorectal Cancer Screening in a VA Medical Center.
Fitzgibbon ML, Ferreira MR, Dolan NC, Davis TC, Rademaker AW, Wolf MS, Dachao Liu, Gorby N, Schmitt BP, Bennett CL
Health promotion practice. 2007;8(3):273-81.
PMID: 17606952
Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project.
Bennett CL, Tigue CC, Angelotta C, McKoy JM, Edwards BJ
Seminars in thrombosis and hemostasis. 2007;33(4):365-72.
PMID: 17525894
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.
Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennett CL
Bone marrow transplantation. 2007.
PMID: 17563736
Cost considerations in the management of cancer in the older patient.
McKoy JM, Fitzner KA, Edwards BJ, Alkhatib M, Tigue CC, Nonzee NJ, Bolden CR, Bennett CL
Oncology (Williston Park, N.Y.). 2007;21(7):851-7; discussion 858, 860, 862 passim.
PMID: 17722744
Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers.
Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW
Archives of internal medicine. 2007;167(10):1041-9.
PMID: 17533207
Long-term safety of filgrastim (rhG-CSF) administration: response to Confer & Miller and Bacher & Zander.
Tigue CC, Trifilio SM, Tallman MS, Goldman JM, Bennett CL
British journal of haematology. 2007;137(1):79-80.
PMID: 17359375
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.
Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI
British journal of haematology. 2007.
PMID: 17459049
Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL, Calhoun EA
The oncologist. 2007;12(4):478-83.
PMID: 17470690
Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm.
Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL
Chest. 2007;131(2):489-96.
PMID: 17296652
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP
Bone marrow transplantation. 2007.
PMID: 17310132
Myeloid growth factors.
Crawford J, Althaus B, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J, Freifeld AG, Heaney ML, Htoy S, Kloth DD, Lyman GH, Messersmith WA, Michaud LB, Miyata SC, Robbins A, Tallman MS, Vadhan-Raj S, Westervelt P, Wong MK
Journal of the National Comprehensive Cancer Network : JNCCN. 2007;5(2):188-202.
PMID: 17335688
Systematic review of piperacillin-induced neutropenia.
Scheetz MH, McKoy JM, Parada JP, Djulbegovic B, Raisch DW, Yarnold PR, Zagory J, Trifilio S, Jakiche R, Palella F, Kahn A, Chandler K, Bennett CL
Drug safety : an international journal of medical toxicology and drug experience. 2007;30(4):295-306.
PMID: 17408306
Cancer-Associated Neutropenic Fever: Clinical Outcome and Economic Costs of Emergency Department Care.
Courtney DM, Aldeen AZ, Gorman SM, Handler JA, Trifilio SM, Parada JP, Yarnold PR, Bennett CL
The oncologist. 2007;12(8):1019-1026.
PMID: 17766662
Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?
Bennett CM, de Jong JL, Neufeld EJ
Pediatric blood & cancer. 2006 Oct;47(5 Suppl):706-9.
PMID: 16933263
Low literacy impairs comprehension of prescription drug warning labels.
Davis TC, Wolf MS, Bass PF 3rd, Middlebrooks M, Kennen E, Baker DW, Bennett CL, Durazo-Arvizu R, Bocchini A, Savory S, Parker RM
Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine. 2006;21(8):847-51.
PMID: 16881945
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(19):3187-205.
PMID: 16682719
When the risk of febrile neutropenia is 20%, prophylactic colony-stimulating factor use is clinically effective, but is it cost-effective?
Adams JR, Angelotta C, Bennett CL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(19):2975-7.
PMID: 16682722
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.
Wolf MS, Knight SJ, Lyons EA, Durazo-Arvizu R, Pickard SA, Arseven A, Arozullah A, Colella K, Ray P, Bennett CL
Urology. 2006;68(1):89-93.
PMID: 16844451
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.
Belknap SM, Kuzel TM, Yarnold PR, Slimack N, Lyons EA, Raisch DW, Bennett CL
Cancer. 2006;106(9):2051-7.
PMID: 16568459
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A
Journal of the National Cancer Institute. 2006;98(10):708-14.
PMID: 16705125
Social stigma concerns and HIV medication adherence.
Rintamaki LS, Davis TC, Skripkauskas S, Bennett CL, Wolf MS
AIDS patient care and STDs. 2006;20(5):359-68.
PMID: 16706710
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.
Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD
Journal of the American College of Cardiology. 2006;47(1):175-81.
PMID: 16386683
Relation between literacy and HIV treatment knowledge among patients on HAART regimens.
Wolf MS, Davis TC, Arozullah A, Penn R, Arnold C, Sugar M, Bennett CL
AIDS care. 2005 Oct;17(7):863-73.
PMID: 16120503
Opportunities for disease state management in prostate cancer.
Pickard AS, Hung SY, McKoy JM, Witt WP, Arseven A, Sharifi R, Wu Z, Knight SJ, McWilliams N, Schumock GT, Bennett CL
Disease management : DM. 2005;8(4):235-44.
PMID: 16117718
Colorectal cancer screening among African-American and white male veterans.
Dolan NC, Ferreira MR, Fitzgibbon ML, Davis TC, Rademaker AW, Liu D, Lee J, Wolf M, Schmitt BP, Bennett CL
American journal of preventive medicine. 2005;28(5):479-82.
PMID: 15894152
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities.
Kramer KM, Bennett CL, Pickard AS, Lyons EA, Wolf MS, McKoy JM, Knight SJ
Clinical prostate cancer. 2005;4(1):15-23.
PMID: 15992457
Prediction rule for atrial fibrillation after major noncardiac thoracic surgery.
Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, Rusch VW
The Annals of thoracic surgery. 2005;79(5):1698-703.
PMID: 15854958
The Research on Adverse Drug Events and Reports (RADAR) project.
Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW
JAMA : the journal of the American Medical Association. 2005;293(17):2131-40.
PMID: 15870417
High rates of adverse drug events in a highly computerized hospital.
Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF
Archives of internal medicine. 2005;165(10):1111-6.
PMID: 15911723
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennett C, Engert A
Journal of the National Cancer Institute. 2005;97(7):489-98.
PMID: 15812074
Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations?
Zakarija A, Bennett CL
Archives of internal medicine. 2005;165(7):722-3.
PMID: 15824289
Development of a brief survey on colon cancer screening knowledge and attitudes among veterans.
Wolf MS, Rademaker A, Bennett CL, Ferreira MR, Dolan NC, Davis TC, Medio F, Liu D, Lee J, Fitzgibbon M
Preventing chronic disease. 2005;2(2):A11.
PMID: 15888222
Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial.
Ferreira MR, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L, Liu D, Rademaker AW, Medio F, Schmitt BP, Bennett CL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005;23(7):1548-54.
PMID: 15735130
Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999.
Rozovsky-Weinberger J, Parada JP, Phan L, Droller DG, Deloria-Knoll M, Chmiel JS, Bennett CL
Chest. 2005;127(1):205-12.
PMID: 15653985
The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best practice & research. Clinical haematology. 2005;18(3):423-31.
PMID: 15792916
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review.
Bohlius JF, Langensiepen S, Engert A, Schwarzer G, Bennett CL
Best practice & research. Clinical haematology. 2005;18(3):449-54.
PMID: 15792919
Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR, Evens AM, Bennett CL, Luminari S
Best practice & research. Clinical haematology. 2005;18(3):467-72.
PMID: 15792921
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Evens AM, Bennett CL, Luminari S
Best practice & research. Clinical haematology. 2005;18(3):481-9.
PMID: 15792923
Granulocyte colony--stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer : the 40% rule revisited.
Calhoun EA, Schumock GT, McKoy JM, Pickard S, Fitzner KA, Heckinger EA, Powell EF, McCaffrey KR, Bennett CL
PharmacoEconomics. 2005;23(8):767-75.
PMID: 16097839
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project.
Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B, Sharma R, Costello S, Toffelmire EB, Wells GA, Messner HA, Yarnold PR, Trifilio SM, Raisch DW, Kuzel TM, Nissenson A, Lim LC, Tallman MS, Casadevall N
Blood. 2005;106(10):3343-7.
PMID: 16099877
Pharmacoeconomics of liposomal anthracycline therapy.
Bennett CL, Calhoun EA
Seminars in oncology. 2004 Dec;31(6 Suppl 13):191-5.
PMID: 15717744
Health literacy and patient knowledge in a Southern US HIV clinic.
Wolf MS, Davis TC, Cross JT, Marin E, Green K, Bennett CL
International journal of STD & AIDS. 2004 Nov;15(11):747-52.
PMID: 15537462
Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
Chang S, Long SR, Kutikova L, Bowman L, Finley D, Crown WH, Bennett CL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(17):3524-30.
PMID: 15337801
Pure red-cell aplasia and epoetin therapy.
Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N
The New England journal of medicine. 2004;351(14):1403-8.
PMID: 15459301
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.
Loblaw DA, Mendelson DS, Talcott JA, Virgo KS, Somerfield MR, Ben-Josef E, Middleton R, Porterfield H, Sharp SA, Smith TJ, Taplin ME, Vogelzang NJ, Wade JL Jr, Bennett CL, Scher HI, American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(14):2927-41.
PMID: 15184404
Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference?
Dolan NC, Ferreira MR, Davis TC, Fitzgibbon ML, Rademaker A, Liu D, Schmitt BP, Gorby N, Wolf M, Bennett CL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(13):2617-22.
PMID: 15226329
Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.
Elstein AS, Chapman GB, Chmiel JS, Knight SJ, Chan C, Nadler RB, Kuzel TM, Siston AK, Bennett CL
Health expectations : an international journal of public participation in health care and health policy. 2004;7(2):115-25.
PMID: 15117386
Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms.
Golub RM, Bennett CL, Stinson T, Venta L, Morrow M
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(12):2430-7.
PMID: 15197205
Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans.
Knight SJ, Siston AK, Chmiel JS, Slimack N, Elstein AS, Chapman GB, Nadler RB, Bennett CL
Clinical prostate cancer. 2004;3(1):31-7.
PMID: 15279688
The financial burden of cancer: estimates from a study of insured women with breast cancer.
Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA, Gorby NS, Schumock GT, Bennett CL
The journal of supportive oncology. 2004;2(3):271-8.
PMID: 15328826
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration.
Zakarija A, Bandarenko N, Pandey DK, Auerbach A, Raisch DW, Kim B, Kwaan HC, McKoy JM, Schmitt BP, Davidson CJ, Yarnold PR, Gorelick PB, Bennett CL
Stroke; a journal of cerebral circulation. 2004;35(2):533-7.
PMID: 14707231
Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.
Patel SM, Johnson S, Belknap SM, Chan J, Sha BE, Bennett C
Journal of acquired immune deficiency syndromes (1999). 2004;35(2):120-5.
PMID: 14722442
US hospital care for patients with HIV infection and pneumonia: the role of public, private, and Veterans Affairs hospitals in the early highly active antiretroviral therapy era.
Uphold CR, Deloria-Knoll M, Palella FJ Jr, Parada JP, Chmiel JS, Phan L, Bennett CL
Chest. 2004;125(2):548-56.
PMID: 14769737
Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Adams JR, Elting LS, Lyman GH, George JN, Lembersky BC, Armitage JO, Demetri GD, Bennett CL
The American journal of medicine. 2004;116(1):28-34.
PMID: 14706663
HIV-related pneumonia care in older patients hospitalized in the early HAART era.
Sureka A, Parada JP, Deloria-Knoll M, Chmiel JS, Phan L, Lyons TM, Ali S, Yarnold PR, Weinstein RA, Dehovitz JA, Jacobson JM, Goetz MB, Campo RE, Berland D, Bennett CL, Uphold CR
AIDS patient care and STDs. 2004;18(2):99-107.
PMID: 15006184
A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
Calhoun EA, Fishman DA, Lurain JR, Welshman EE, Bennett CL
Gynecologic oncology. 2004;93(1):164-9.
PMID: 15047231
Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s.
Kim SP, Feinglass J, Bennett CL, Lyons T, Simon C, Weinberg MN, Talamonti MS
Cancer investigation. 2004;22(2):225-33.
PMID: 15199605
Relationship between health insurance and medical care for patients hospitalized with human immunodeficiency virus-related Pneumocystis carinii pneumonia, 1995-1997: Medicaid, bronchoscopy, and survival.
Parada JP, Deloria-Knoll M, Chmiel JS, Arozullah AM, Phan L, Ali SN, Goetz MB, Weinstein RA, Campo R, Jacobson J, Dehovitz J, Berland D, Bennett CL
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003 Dec;37(11):1549-55.
PMID: 14614679
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project.
Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Oct;21(20):3859-66.
PMID: 14551305
Cost analyses of granulocyte colony stimulating factor: a focus on older patients with cancer.
Bennett CL
Critical reviews in oncology/hematology. 2003 Oct;48(Suppl):S71-4.
PMID: 14563524
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion.
Talamonti MS, Kim SP, Yao KA, Wayne JD, Feinglass J, Bennett CL, Rao S
Surgery. 2003 Oct;134(4):720-7; discussion 727-9.
PMID: 14605635
A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia.
Arozullah AM, Parada J, Bennett CL, Deloria-Knoll M, Chmiel JS, Phan L, Yarnold PR
Chest. 2003;123(4):1151-60.
PMID: 12684306
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations.
Bennett CL, Somerfield MR, Pfister DG, Tomori C, Yakren S, Bach PB, American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(5):937-41.
PMID: 12610197
Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization.
MacDonald LA, Meyers S, Bennett CL, Fintel D, Grosshans N, Syegco R, Davidson CJ
The Journal of invasive cardiology. 2003;15(2):60-2.
PMID: 12556615
Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study.
Siston AK, Knight SJ, Slimack NP, Chmiel JS, Nadler RB, Lyons TM, Kuzel TM, Moran EM, Sharifi R, Bennett CL, Veterans Affairs Cancer of the Prostate Outcomes Study
Urology. 2003;61(1):172-8.
PMID: 12559291
Evaluating the total costs of cancer. The Northwestern University Costs of Cancer Program.
Calhoun EA, Bennett CL
Oncology (Williston Park, N.Y.). 2003;17(1):109-14; discussion 119-21.
PMID: 12599935
Cost analyses of adjunct colony stimulating factors for older patients with acute myeloid leukaemia : can they improve clinical decision making?
Bennett CL, Schumock GT
Drugs & aging. 2003;20(7):479-83.
PMID: 12749746
Priorities in colorectal cancer research: recommendations from the gastrointestinal scientific leadership council of the coalition of cancer cooperative groups.
O'dwyer PJ, Eckhardt SG, Haller DG, Tepper J, Ahnen D, Hamilton S, Benson AB 3rd, Rothenberg M, Petrelli N, Lenz HJ, Diasio R, Dubois R, Sargent D, Sloan J, Johnson CD, Comis RL, O'connell MJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(16):2313-21.
PMID: 17538178
Chemotherapy-induced mucositis: focusing on diarrhea.
Wisinski K, Benson A 3rd
The journal of supportive oncology. 2007;5(6):270-1.
PMID: 17624051
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, Benson A 3rd, Espat J, Bilbao JI, Sharma RA, Thomas JP, Coldwell D
International journal of radiation oncology, biology, physics. 2007;68(1):13-23.
PMID: 17448867
Bevacizumab in the treatment of colorectal cancer.
Cilley JC, Barfi K, Benson AB, Mulcahy MF
Expert opinion on biological therapy. 2007;7(5):739-749.
PMID: 17477810
NCCN Task Force Report: Positron Emission Tomography (PET)/Computed Tomography (CT) Scanning in Cancer.
Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW Jr, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD
Journal of the National Comprehensive Cancer Network : JNCCN. 2007;5 Suppl 1:S1-S22.
PMID: 17509259
Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers.
Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW
Archives of internal medicine. 2007;167(10):1041-9.
PMID: 17533207
Current issues in rectal cancer chemotherapy.
Joseph M, Benson AB 3rd
Cancer journal (Sudbury, Mass.). 2007;13(3):198-203.
PMID: 17620770
Desmoplastic small round-cell tumor of the pancreas.
Ryan A, Razak A, Graham J, Benson A, Rowe D, Haugk B, Verrill M
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(11):1440-2.
PMID: 17416866
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200.
Giantonio BJ, Catalano PJ, Meropol NJ, O'dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB 3rd
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(12):1539-44.
PMID: 17442997
The Hope for Today--The Promise for Tomorrow: Will Oncologists Meet the Challenge?
Benson AB 3rd
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007.
PMID: 17470848
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
Marsh Rde W, Lima CM, Levy DE, Mitchell EP, Rowland KM Jr, Benson AB 3rd
American journal of clinical oncology. 2007;30(1):26-31.
PMID: 17278891
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
Lenz HJ, Lee FC, Haller DG, Singh D, Benson AB 3rd, Strumberg D, Yanagihara R, Yao JC, Phan AT, Ajani JA
Cancer. 2007;109(1):33-40.
PMID: 17133415
The continuum of care: a paradigm for the management of metastatic colorectal cancer.
Goldberg RM, Rothenberg ML, Van Cutsem E, Benson AB 3rd, Blanke CD, Diasio RB, Grothey A, Lenz HJ, Meropol NJ, Ramanathan RK, Becerra CH, Wickham R, Armstrong D, Viele C
The oncologist. 2007;12(1):38-50.
PMID: 17227899
Adjuvant therapy for pancreatic cancer: one small step forward.
Benson AB 3rd
JAMA : the journal of the American Medical Association. 2007;297(3):311-3.
PMID: 17227984
Panitumumab in metastatic colorectal cancer.
Wisinski KB, Mulcahy MF, Benson AB 3rd
Clinical advances in hematology & oncology : H&O. 2007;5(1 Suppl 1):10-1.
PMID: 17491586
Bevacizumab in combination with 5-fluorouracil-based chemotherapy in the second-line treatment of metastatic colorectal cancer.
Benson AB 3rd
Clinical advances in hematology & oncology : H&O. 2006 Oct;4(10):747.
PMID: 17111559
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.
Giantonio BJ, Levy DE, O'dwyer PJ, Meropol NJ, Catalano PJ, Benson AB 3rd, Eastern Cooperative Oncology Group
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2006;17(9):1399-403.
PMID: 16873427
Hepatobiliary cancers. Clinical practice guidelines in oncology.
Benson AB 3rd, Bekaii-Saab T, Ben-Josef E, Blumgart L, Clary BM, Curley SA, Davila R, Earle CC, Ensminger WD, Gibbs JF, Laheru D, Langnas AN, Mulvihill SJ, Nemcek AA Jr, Posey JA, Sigurdson ER, Sinanan M, Vauthey JN, Venook AP, Wagman LD, Yeatman TJ, National Comprehensive Cancer Network
Journal of the National Comprehensive Cancer Network : JNCCN. 2006;4(8):728-50.
PMID: 16948952
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB 3rd, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(22):3542-7.
PMID: 16877719
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.
Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B, Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de Velde C
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2006;17 Suppl 6:vi13-8.
PMID: 16809641
Endoscopic sedation in the United States: results from a nationwide survey.
Cohen LB, Wecsler JS, Gaetano JN, Benson AA, Miller KM, Durkalski V, Aisenberg J
The American journal of gastroenterology. 2006;101(5):967-74.
PMID: 16573781
The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors.
Lacouture ME, Basti S, Patel J, Benson A 3rd
The journal of supportive oncology. 2006;4(5):236-8.
PMID: 16724647
Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(4):663-7.
PMID: 16446338
Neuroendocrine tumors.
Clark OH, Ajani J, Benson AB 3rd, Byrd D, Doherty GM, Engstrom PF, Ettinger DS, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kvols L, Nemcek AA Jr, Olson JA Jr, Ratliff TW, Saltz L, Schteingart DE, Shah MH, Shibata S, National Comprehensive Cancer Network
Journal of the National Comprehensive Cancer Network : JNCCN. 2006;4(2):102-38.
PMID: 16451769
New approaches to the adjuvant therapy of colon cancer.
Benson AB 3rd
The oncologist. 2006;11(9):973-80.
PMID: 17030637
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
Rothenberg ML, LaFleur B, Levy DE, Washington MK, Morgan-Meadows SL, Ramanathan RK, Berlin JD, Benson AB 3rd, Coffey RJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Dec;23(36):9265-74.
PMID: 16361624
Adjuvant chemotherapy of stage III colon cancer.
Benson AB 3rd
Seminars in oncology. 2005 Dec;32(6 Suppl 9):S74-7.
PMID: 16399437
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.
Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ, American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Nov;23(33):8512-9.
PMID: 16260687
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP, American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Oct;23(30):7703-20.
PMID: 16157938
In search of evidence: is there the will and a way?
Benson AB 3rd
Archives of internal medicine. 2005 Oct;165(19):2194-5.
PMID: 16246979
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
Tempero MA, Behrman S, Ben-Josef E, Benson AB 3rd, Cameron JL, Casper ES, Hoffman JP, Karl RC, Kim P, Koh WJ, Kuvshinoff BW 2nd, Melvin WS, Muscarella P 2nd, Sasson AR, Shibata S, Shrieve DC, Talamonti MS, Tyler DS, Vickers SM, Warren RS, Willett C, Wolff RA, National Comprehensive Cancer Network
Journal of the National Comprehensive Cancer Network : JNCCN. 2005;3(5):598-626.
PMID: 16194453
A phase II study of gemcitabine and cisplatin in patients with advanced hepatocellular carcinoma.
Parikh PM, Fuloria J, Babu G, Doval DC, Awasthy BS, Pai VR, Prabhakaran PS, Benson AB
Tropical gastroenterology : official journal of the Digestive Diseases Foundation. 2005;26(3):115-8.
PMID: 16512457
Adjuvant therapy in stage II colon cancer: current approaches.
Baddi L, Benson A 3rd
The oncologist. 2005;10(5):325-31.
PMID: 15851790
The assessment and management of cancer treatment-related diarrhea.
O'Brien BE, Kaklamani VG, Benson AB 3rd
Clinical colorectal cancer. 2005;4(6):375-81; discussion 382-3.
PMID: 15807929
Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.
Larson GP, Ding Y, Cheng LS, Lundberg C, Gagalang V, Rivas G, Geller L, Weitzel J, MacDonald D, Archambeau J, Slater J, Neuberg D, Daly MB, Angel I, Benson AB 3rd, Smith K, Kirkwood JM, O'Dwyer PJ, Raskay B, Sutphen R, Drew R, Stewart JA, Werndli J, Johnson D, Ruckdeschel JC, Elston RC, Krontiris TG
Cancer research. 2005;65(3):805-14.
PMID: 15705877
Ostomy care: the added considerations for cancer patients.
O'Brien B, Baddi L, Benson A 3rd
The journal of supportive oncology. 2005;3(1):71-2.
PMID: 15724948
Bevacizumab in the treatment of colorectal cancer.
Mulcahy MF, Benson AB 3rd
Expert opinion on biological therapy. 2005;5(7):997-1005.
PMID: 16018743
Colon cancer clinical practice guidelines in oncology.
Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network
Journal of the National Comprehensive Cancer Network : JNCCN. 2005;3(4):468-91.
PMID: 16038639
Rectal cancer clinical practice guidelines in oncology.
Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network
Journal of the National Comprehensive Cancer Network : JNCCN. 2005;3(4):492-508.
PMID: 16038640
Anal canal cancer clinical practice guidelines in oncology.
Engstrom PF, Benson AB 3rd, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW Jr, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ, National Comprehensive Cancer Network
Journal of the National Comprehensive Cancer Network : JNCCN. 2005;3(4):510-5.
PMID: 16038641
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Dec;22(23):4753-61.
PMID: 15570076
Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.
McGartland LP, Mulcahy MF, Benson AB 3rd
Clinical advances in hematology & oncology : H&O. 2004 Dec;2(12):806-14.
PMID: 16166957
An exploration of relative health stock in advanced cancer patients.
Gaskin DJ, Weinfurt KP, Castel LD, DePuy V, Li Y, Balshem A, Benson A, Burnett CB, Corbett S, Marshall J, Slater E, Sulmasy DP, Van Echo D, Meropol NJ, Schulman KA
Medical decision making : an international journal of the Society for Medical Decision Making. 2004 Nov;24(6):614-24.
PMID: 15534342
Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: phase II trial (E8296) of the Eastern Cooperative Oncology Group.
Armanios M, Xu R, Forastiere AA, Haller DG, Kugler JW, Benson AB 3rd, Eastern Cooperative Oncology Group
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Nov;22(22):4495-9.
PMID: 15542799
Adenocarcinoma arising in rectal duplication cyst: case report and review of the literature.
Shivnani AT, Small W Jr, Benson A 3rd, Rao S, Talamonti MS
The American surgeon. 2004 Nov;70(11):1007-9.
PMID: 15586516
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(16):3408-19.
PMID: 15199089
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130.
Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL, Thomas CR Jr, Fisher B, Benson AB 3rd, Myerson R, Goldberg RM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(16):3277-83.
PMID: 15249584
Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
Benson AB 3rd, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA Jr, McCallum R, Mitchell EP, O'Dorisio TM, Vokes EE, Wadler S
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(14):2918-26.
PMID: 15254061
Clinical practice. Surveillance strategies after curative treatment of colorectal cancer.
Pfister DG, Benson AB 3rd, Somerfield MR
The New England journal of medicine. 2004;350(23):2375-82.
PMID: 15175439
MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials.
Extermann M, Bonetti M, Sledge GW, O'Dwyer PJ, Bonomi P, Benson AB 3rd
European journal of cancer (Oxford, England : 1990). 2004;40(8):1193-8.
PMID: 15110883
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, O'Connell MJ, Mayer RJ, Cummings B, Willett C, Macdonald JS, Benson AB 3rd, Fuchs CS
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(4):648-57.
PMID: 14966087
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RJ, Willett CG, MacDonald JS, Benson AB 3rd, Fuchs CS
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(1):166-74.
PMID: 14701779
A rose, is a rose, is a rose...or not.
Benson AB 3rd, Catalano PJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004;22(10):1773-5.
PMID: 15067029
Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma (E1298). A trial of the eastern cooperative oncology group.
Shepard RC, Levy DE, Berlin JD, Stuart K, Harris JE, Aviles V, Thomas JP, Benson AB 3rd
Oncology. 2004;66(4):303-9.
PMID: 15218298
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
Meyerhardt JA, Catalano PJ, Schrag D, Ayanian JZ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS
Annals of internal medicine. 2003 Oct;139(8):649-57.
PMID: 14568853
Irinotecan and paclitaxel in metastatic adenocarcinoma of the esophagus and gastric cardia.
Hecht JR, Blanke CD, Benson AB 3rd, Lenz HJ
Oncology (Williston Park, N.Y.). 2003;17(9 Suppl 8):13-5.
PMID: 14569841
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, Fuchs CS
Cancer. 2003;98(3):484-95.
PMID: 12879464
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.
Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(13):2589-96.
PMID: 12829680
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB 3rd, Burnett CB, Gaskin DJ, Marshall JL, Slater EF, Schulman KA, Meropol NJ
Cancer. 2003;98(1):166-75.
PMID: 12833469
Optimal use of the combination of irinotecan and 5-fluorouracil.
Benson AB 3rd, Goldberg RM
Seminars in oncology. 2003;30(3 Suppl 6):68-77.
PMID: 12802797
ZD9331 in combination with topotecan: phase I and II experience.
Benson A 3rd, Poplin E, Vergote I
Anti-cancer drugs. 2003;14 Suppl 1:S21-7.
PMID: 14567437
Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
Johnston PG, Benson AB 3rd, Catalano P, Rao MS, O'Dwyer PJ, Allegra CJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(5):815-9.
PMID: 12610179
The clients' experience of the community group: implications for nurse facilitators.
Harms S, Benson A
Journal of psychiatric and mental health nursing. 2003;10(1):49-56.
PMID: 12558921
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003;21(3):433-40.
PMID: 12560431
Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.
Craft CS, Romero D, Vary CP, Bergan RC
Oncogene. 2007.
PMID: 17496924
Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
Xu L, Bergan RC
Molecular pharmacology. 2006;70(3):869-77.
PMID: 16772519
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer.
Eklund J, Kozloff M, Vlamakis J, Starr A, Mariott M, Gallot L, Jovanovic B, Schilder L, Robin E, Pins M, Bergan RC
Cancer. 2006;106(11):2459-65.
PMID: 16615097
MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L, Chen S, Bergan RC
Oncogene. 2006;25(21):2987-98.
PMID: 16407830
Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
Ding Y, Xu L, Chen S, Jovanovic BD, Helenowski IB, Kelly DL, Catalona WJ, Yang XJ, Pins M, Ananthanarayanan V, Bergan RC
Prostate cancer and prostatic diseases. 2006;9(4):379-91.
PMID: 16786039
Renal medullary carcinoma and ABL gene amplification.
Simpson L, He X, Pins M, Huang X, Campbell SC, Yang XJ, Perlman EJ, Bergan RC
The Journal of urology. 2005;173(6):1883-8.
PMID: 15879768
Safety and efficacy of weekly oral oltipraz in chronic smokers.
Kelley MJ, Glaser EM, Herndon JE 2nd, Becker F, Bhagat R, Zhang YJ, Santella RM, Carmella SG, Hecht SS, Gallot L, Schilder L, Crowell JA, Perloff M, Folz RJ, Bergan RC
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14(4):892-9.
PMID: 15824161
Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells.
Huang X, Chen S, Xu L, Liu Y, Deb DK, Platanias LC, Bergan RC
Cancer research. 2005;65(8):3470-8.
PMID: 15833883
Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM, Vogelzang NJ, Teh BT
Cancer. 2004;100(5):976-85.
PMID: 14983493
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer.
Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, Quinn M, Jovanovic BD, Shapiro A, Hernandez L, Goetz A, Llorens V, Lieberman R, Crowell JA, Poisson BA, Bergan RC
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2003 Nov;12(11 Pt 1):1213-21.
PMID: 14652284
p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion.
Hayes SA, Huang X, Kambhampati S, Platanias LC, Bergan RC
Oncogene. 2003;22(31):4841-50.
PMID: 12894225
Cancer patients, opioids, and driving.
Brandman JF
The journal of supportive oncology. 2005;3(4):317-20.
PMID: 16092605
Optimizing endocrine therapy for premenopausal and postmenopausal women with breast cancer.
Cianfrocca M, Wolff AC
Oncology (Williston Park, N.Y.). 2007;21(1):63-9; discussion 69, 72, 75 passim.
PMID: 17313157
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours.
Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, Shaw DE, Mazar AP, Cohen RB
British journal of cancer. 2006;94(11):1621-6.
PMID: 16705310
Peripheral neuropathy in a woman with breast cancer.
Cianfrocca M, Flatters SJ, Bennett GJ, McNicol E, Relias V, Carr D, Gillis TA
The journal of pain : official journal of the American Pain Society. 2006;7(1):2-10.
PMID: 16414547
STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.
Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD
The Journal of clinical investigation. 2007 Dec;117(12):3890-3899.
PMID: 18060035
Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Norton A, Fisher C, Liu H, Wen Q, Mundschau G, Fuster JL, Hasle H, Zeller B, Webb DK, O'marcaigh A, Sorrell A, Hilden J, Gamis A, Crispino JD, Vyas P
Blood. 2007;110(3):1077-9.
PMID: 17644747
Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells.
Leung CG, Xu Y, Mularski B, Liu H, Gurbuxani S, Crispino JD
The Journal of experimental medicine. 2007.
PMID: 17576776
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders.
Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM
Blood. 2007.
PMID: 17420284
Molecular insights into Down syndrome-associated leukemia.
Vyas P, Crispino JD
Current opinion in pediatrics. 2007;19(1):9-14.
PMID: 17224656
Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization.
Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD
Blood. 2007.
PMID: 17317855
Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, Crispino JD
Blood. 2007.
PMID: 17901249
Erythroid and megakaryocytic transformation.
Wickrema A, Crispino JD
Oncogene. 2007;26(47):6803-15.
PMID: 17934487
MTB, the murine homolog of condensin II subunit CAP-G2, represses transcription and promotes erythroid cell differentiation.
Xu Y, Leung CG, Lee DC, Kennedy BK, Crispino JD
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2006;20(7):1261-9.
PMID: 16673016
GATA1s goes germline.
Mundschau G, Crispino J
Nature genetics. 2006;38(7):741-2.
PMID: 16804537
Activating alleles of JAK3 in acute megakaryoblastic leukemia.
Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M, Goss VL, Lee KA, Eide CA, Wong MJ, Stoffregen EP, McGreevey L, Nardone J, Moore SA, Crispino J, Boggon TJ, Heinrich MC, Deininger MW, Polakiewicz RD, Gilliland DG, Druker BJ
Cancer cell. 2006;10(1):65-75.
PMID: 16843266
Transcription factor GATA-1 and Down syndrome leukemogenesis.
Muntean AG, Ge Y, Taub JW, Crispino JD
Leukemia & lymphoma. 2006;47(6):986-97.
PMID: 16840187
Differential requirements for the activation domain and FOG-interaction surface of GATA-1 in megakaryocyte gene expression and development.
Muntean AG, Crispino JD
Blood. 2005;106(4):1223-31.
PMID: 15860665
GATA1 in normal and malignant hematopoiesis.
Crispino JD
Seminars in cell & developmental biology. 2005;16(1):137-47.
PMID: 15659348
GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
Crispino JD
Pediatric blood & cancer. 2005;44(1):40-4.
PMID: 15390312
Differential requirements for survivin in hematopoietic cell development.
Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD
Proceedings of the National Academy of Sciences of the United States of America. 2005;102(32):11480-5.
PMID: 16055565
Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome.
Taub JW, Mundschau G, Ge Y, Poulik JM, Qureshi F, Jensen T, James SJ, Matherly LH, Wechsler J, Crispino JD
Blood. 2004;104(5):1588-9.
PMID: 15317736
More than blood, a novel gene required for mammalian postimplantation development.
Smith ED, Xu Y, Tomson BN, Leung CG, Fujiwara Y, Orkin SH, Crispino JD
Molecular and cellular biology. 2004;24(3):1168-73.
PMID: 14729962
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
Gurbuxani S, Vyas P, Crispino JD
Blood. 2004;103(2):399-406.
PMID: 14512321
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD
Blood cells, molecules & diseases. 2003 Nov;31(3):351-6.
PMID: 14636651
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.
Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD
Blood. 2003;101(11):4298-300.
PMID: 12560215
Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo.
Karnauskas R, Niu Q, Talapatra S, Plas DR, Greene ME, Crispino JD, Rudin CM
Oncogene. 2003;22(5):688-98.
PMID: |
|
|
